Brief: Celularity Announces Advisory Guidance From Tamer Group
10/05/2023 14:38
May 10 (Reuters) - Celularity Inc CELU.O :
* CELULARITY ANNOUNCES ADVISORY GUIDANCE FROM TAMER GROUP
REGARDING ANTICIPATED 2023 PURCHASE ORDERS FOR CELULARITY
BRANDED HALAL-CERTIFIED BIOMATERIAL PRODUCTS
* CELULARITY - ADVISED BY TAMER GROUP TO EXPECT AT LEAST $60
MILLION - $80 MILLION IN 2023 PURCHASE ORDERS FOR CO'S BRANDED
HALAL-CERTIFIED BIOMATERIAL PRODUCTS
Source text for Eikon: ID:nGNX3jWjYJ
Further company coverage: CELU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celularity
See all newsU.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Celularity hits over 4-month high on deal to manufacture MuseCell's cell therapy platform
Celularity rises on deal to manufacture MuseCell's cell therapy platform
Brief: Celularity And MuseCell Innovations® Announce U.S. Manufacturing Collaboration For The Dezawa Musecell® Platform